We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Synopsys, Inc (SNPS) is a leading software-infrastructure business with stocks listed in the US. It opened the day at US$250.38 after a previous close of US$252.51. During the day the price has varied from a low of USD246.02 to a high of USD252.47. The latest price was USD247.06 (25 minute delay). Synopsys is listed on the NASDAQ. All prices are listed in US Dollars.
How to buy shares in Synopsys
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Synopsys. Find the share by name or ticker symbol: SNPS. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Synopsys reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$237.46, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Synopsys, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Synopsys. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Synopsys key stats
- Compare share trading platforms
- Is Synopsys stock a buy or sell?
- Synopsys performance over time
- Can I short Synopsys shares?
- Is Synopsys suitable for ethical investing?
- Are Synopsys shares over-valued?
- Synopsys's financials
- How volatile are Synopsys shares?
- Does Synopsys pay a dividend?
- Have Synopsys shares ever split?
- Other common questions
Synopsys share priceUse our graph to track the performance of SNPS stocks over time.
Synopsys shares at a glance
|52-week range||US$147.98 - US$300.91|
|50-day moving average||US$243.3229|
|200-day moving average||US$244.0386|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$4.625|
Standard brokerage - US shares
Share Trading Account Offer
Get $0 brokerage on US stocks with trades as little as $50 when you join the world's biggest social trading network.
- $0 brokerage for US stocks
- Trades starting from $50
- Fractional shares
- Copy top traders
Important: Share trading carries risk of capital loss.
Disclaimer: Trading CFDs and forex on leverage is high-risk and losses could exceed your deposits.
Compare share trading platforms to buy stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Synopsys stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Synopsys price performance over time
|1 week (2021-04-28)||-1.71%|
|1 month (2021-04-08)||-5.34%|
|3 months (2021-02-08)||-10.64%|
|6 months (2020-11-06)||2.18%|
|1 year (2020-05-08)||54.25%|
|2 years (2019-05-08)||106.99%|
|3 years (2018-05-08)||177.44%|
|5 years (2016-05-06)||416.21%|
Is Synopsys under- or over-valued?
Valuing Synopsys stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Synopsys's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Synopsys's P/E ratio
Synopsys's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 54x. In other words, Synopsys shares trade at around 54x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Synopsys's PEG ratio
Synopsys's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.5881. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Synopsys's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Synopsys's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$866.2 million (£0.0 million).
The EBITDA is a measure of a Synopsys's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||US$3.8 billion|
|Operating margin TTM||18.54%|
|Gross profit TTM||US$2.9 billion|
|Return on assets TTM||5.82%|
|Return on equity TTM||15.96%|
|Market capitalisation||US$38.8 billion|
TTM: trailing 12 months
Shorting Synopsys shares
There are currently 1.6 million Synopsys shares held short by investors – that's known as Synopsys's "short interest". This figure is 8.7% down from 1.8 million last month.
There are a few different ways that this level of interest in shorting Synopsys shares can be evaluated.
Synopsys's "short interest ratio" (SIR)
Synopsys's "short interest ratio" (SIR) is the quantity of Synopsys shares currently shorted divided by the average quantity of Synopsys shares traded daily (recently around 1.2 million). Synopsys's SIR currently stands at 1.43. In other words for every 100,000 Synopsys shares traded daily on the market, roughly 1430 shares are currently held short.
However Synopsys's short interest can also be evaluated against the total number of Synopsys shares, or, against the total number of tradable Synopsys shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Synopsys's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Synopsys shares in existence, roughly 10 shares are currently held short) or 0.0123% of the tradable shares (for every 100,000 tradable Synopsys shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Synopsys.
Find out more about how you can short Synopsys stock.
Synopsys's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Synopsys.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Synopsys's total ESG risk score
Total ESG risk: 21.54
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Synopsys's overall score of 21.54 (as at 12/31/2018) is excellent – landing it in it in the 14th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Synopsys is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Synopsys's environmental score
Environmental score: 9.6/100
Synopsys's environmental score of 9.6 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Synopsys is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Synopsys's social score
Social score: 14.57/100
Synopsys's social score of 14.57 puts it squarely in the 9th percentile of companies rated in the same sector. This could suggest that Synopsys is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Synopsys's governance score
Governance score: 9.87/100
Synopsys's governance score puts it squarely in the 9th percentile of companies rated in the same sector. That could suggest that Synopsys is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Environmental, social, and governance (ESG) summary
|Total ESG score||21.54|
|Total ESG percentile||14.2|
|Environmental score percentile||9|
|Social score percentile||9|
|Governance score percentile||9|
Synopsys share dividends
We're not expecting Synopsys to pay a dividend over the next 12 months.
Have Synopsys's shares ever split?
Synopsys's shares were split on a 2:1 basis on 23 September 2003. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Synopsys shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Synopsys shares which in turn could have impacted Synopsys's share price.
Synopsys share price volatility
Over the last 12 months, Synopsys's shares have ranged in value from as little as US$147.98 up to US$300.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Synopsys's is 1.0678. This would suggest that Synopsys's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. The company also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating point components, and Arm AMBA interconnect fabric and peripherals. In addition, it offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, the company provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, it offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle; manufacturing solutions; and professional and other services. It has a collaboration with IBM Research's AI Hardware Center to advance the development of chip architectures and design methodologies critical to the next generation of AI chips. Synopsys, Inc. was founded in 1986 and is headquartered in Mountain View, California.
Frequently asked questions
Ask an Expert